251 related articles for article (PubMed ID: 32922202)
1. Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
Wang J; Yi Y; Chen Y; Xiong Y; Zhang W
Int J Med Sci; 2020; 17(15):2362-2372. PubMed ID: 32922202
[TBL] [Abstract][Full Text] [Related]
2. Reconstruction and analysis of circRNA‑miRNA‑mRNA network in the pathology of cervical cancer.
Yi Y; Liu Y; Wu W; Wu K; Zhang W
Oncol Rep; 2019 Apr; 41(4):2209-2225. PubMed ID: 30816541
[TBL] [Abstract][Full Text] [Related]
3. The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients.
Su YF; Wu TF; Ko JL; Tsai HT; Tee YT; Chien MH; Chou CH; Lin WL; Low HY; Chou MY; Yang SF; Wang PH
PLoS One; 2014; 9(3):e91644. PubMed ID: 24637958
[TBL] [Abstract][Full Text] [Related]
4. Identification of lncRNA NEAT1/miR-21/RRM2 axis as a novel biomarker in breast cancer.
Quan D; Chen K; Zhang J; Guan Y; Yang D; Wu H; Wu S; Lv L
J Cell Physiol; 2020 Apr; 235(4):3372-3381. PubMed ID: 31621912
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
Zhao H; Zheng GH; Li GC; Xin L; Wang YS; Chen Y; Zheng XM
J Cell Physiol; 2019 Dec; 234(12):23349-23359. PubMed ID: 31169309
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer.
Wu L; Yin L; Ma L; Yang J; Yang F; Sun B; Nianzeng X
Aging (Albany NY); 2022 Oct; 14(19):7890-7905. PubMed ID: 36202136
[TBL] [Abstract][Full Text] [Related]
7. Co-expression network analysis identified atypical chemokine receptor 1 (ACKR1) association with lymph node metastasis and prognosis in cervical cancer.
Liu J; Li S; Lin L; Jiang Y; Wan Y; Zhou S; Cheng W
Cancer Biomark; 2020; 27(2):213-223. PubMed ID: 32083574
[TBL] [Abstract][Full Text] [Related]
8. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
[TBL] [Abstract][Full Text] [Related]
9. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.
Han P; Lin ZR; Xu LH; Zhong Q; Zhu XF; Liang FY; Cai Q; Huang XM; Zeng MS
Mol Med Rep; 2015 Jul; 12(1):401-9. PubMed ID: 25695839
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
[TBL] [Abstract][Full Text] [Related]
11. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M; Sun Y; Wu J; Liu G
Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
[TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
[TBL] [Abstract][Full Text] [Related]
13. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL
Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis revealing prognostic significance of
Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
[No Abstract] [Full Text] [Related]
15. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
Tu S; Zhang H; Yang X; Wen W; Song K; Yu X; Qu X
Cancer Biomark; 2021; 32(3):303-315. PubMed ID: 34151839
[TBL] [Abstract][Full Text] [Related]
16. Novel Genomic Biomarker Candidates for Cervical Cancer As Identified by Differential Co-Expression Network Analysis.
Kori M; Gov E; Arga KY
OMICS; 2019 May; 23(5):261-273. PubMed ID: 31038390
[TBL] [Abstract][Full Text] [Related]
17. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma.
Das B; Jain N; Mallick B
Gene; 2022 Jan; 808():145988. PubMed ID: 34624457
[TBL] [Abstract][Full Text] [Related]
18. Screening a Prognosis-Related Target Gene in Patients with HER-2-Positive Breast Cancer by Bioinformatics Analysis.
Wang S; Deng J; Gao X; Lv H; Quan Y
Med Princ Pract; 2021; 30(4):376-384. PubMed ID: 33823519
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
[TBL] [Abstract][Full Text] [Related]
20. The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer.
Li P; Xu M; Cai H; Thapa N; He C; Song Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
